Home / Our Services / Regulatory Services

Navigating Regulations

Expert regulatory guidance to accelerate your success.

Global Regulatory Affair Services:

Regulatory Strategy Development

  • Tailored regulatory strategies for clinical trial design and development
  • Regulatory pathway assessments for global markets
  • Risk-based regulatory planning and decision-making

Regulatory Submissions and Filings

  • Preparation and submission of Investigational New Drug (IND) applications
  • New Drug Application (NDA), Biological License Application (BLA), and Orphan Drug Designation (ODD) submissions
  • Clinical trial application (CTA) preparation and submissions to regulatory authorities (FDA, MHRA, Health Canada, EMA, etc.)

Regulatory Compliance and Guidance

  • Compliance support for Good Clinical Practice (GCP) and ICH guidelines
  • Regulatory inspection preparation and support
  • Addressing regulatory queries and maintaining ongoing communication with health authorities

Global Regulatory Affairs Consulting

  • Market-specific regulatory requirements and market access strategies
  • Interaction with regulatory bodies across regions 

Clinical Trial Application (CTA) and Ethics Committee Submissions

  • Coordination and submission of trial protocols to ethics committees and regulatory bodies
  • Support in navigating ethical approvals in multiple jurisdictions

Health Authority Liaison and Communication

  • Management of meetings with global regulatory authorities
  • Preparation for meetings and presentations with regulatory agencies
  • Negotiation of regulatory outcomes with local authorities

Regulatory Intelligence and Monitoring

  • Tracking evolving global regulatory requirements and guidelines
  • Impact assessment of regulatory changes on clinical trial strategy
  • Providing insights into trends and best practices in global regulatory affairs

Training and Support

  • Regulatory affairs training for clinical trial teams
  • Workshops on compliance, clinical trial submission processes, and global regulatory environment
  • Ongoing support to ensure adherence to evolving regulations and guidelines

Case Study: Tuberous Sclerosis Complex Phase III / IV Trial

A global biopharmaceutical company was conducting a clinical trial for a novel drug intended for the treatment of symptoms associated with Tuberous Sclerosis Complex. The client needed to submit the trial for approval across multiple regions, including the United States, United Kingdom, Poland, and Canada.

View the Latest News & Insights

Explore our expert insights, industry news, and valuable resources for biotech innovation.

Focused Expertise, Meaningful Impact

Our commitment extends to ensuring you feel supported and informed at every stage. We strive to provide the best regulatory and ethical advice through open dialogue and a collaborative spirit.

Partner With Us

When every decision matters, we make sure you get them right.